GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Share Analysis
NSE · Healthcare · Pharmaceuticals
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹2,673.00, P/E 40, ROE 45.6%.
Get the AI verdict on GLAXO: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
GLAXO chart with trendlines
Is GLAXO a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About GlaxoSmithKline Pharmaceuticals Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
GLAXO key facts
| Price and valuation | |
|---|---|
| Share price | ₹2,673.00 |
| Market cap | ₹45,275 Cr |
| P/E ratio | 40 |
| P/B ratio | 24.08 |
| EPS | ₹67.68 |
| Book value per share | ₹111.00 |
| Dividend yield | 2.13% |
| 52-week range | |
| 52-week high | ₹3,120.70 |
| 52-week low | ₹2,088.10 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 75% |
| FIIs | 4.75% |
| DIIs | 8.47% |
| Public | 11.77% |
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.